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Abstract Ionotropic glutamate receptors are the most impor-
tant excitatory receptors in the central nervous system, and
their impairment can lead to multiple neuronal diseases. Here,
we show that glutamate-induced currents in oocytes expressing
GluA1 are increased by coexpression of the schizophrenia-
associated phosphoinositide kinase PIP5K2A. This effect was
due to enhanced membrane abundance and was blunted by a
point mutation (N251S) in PIP5K2A. An increase in GluA1
currents was also observed upon acute injection of PI(4,5)P2,
the main product of PIP5K2A. By expression of wild-type and
mutant PIP5K2A in human embryonic kidney cells, we were
able to provide evidence of impaired kinase activity of the
mutant PIP5K2A. We defined the region K813–K823 of
GluA1 as critical for the PI(4,5)P2 effect by performing an
alanine scan that suggested PI(4,5)P2 binding to this area. A
PIP strip assay revealed PI(4,5)P2 binding to the C-terminal
GluA1 peptide. The present observations disclose a novel
mechanism in the regulation of GluA1.
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Introduction
Ionotropic glutamate receptors are the most important media-
tors of excitatory signal transduction in the central nervous
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system [35, 36]. They can be pharmacologically classified in
three distinct classes: α-amino-3-hydroxy-5-methyl-4-
isoxazole propionic acid (AMPA), kainate, and NMDA re-
ceptors. The family of the AMPA receptors consists of
four subunits, GluA1–4 (GluR1–4, GluRA–D) [41]. The
activation of AMPA-type glutamate receptors through
the binding of glutamate leads to the activation of a
multitude of biochemical pathways in postsynaptic neu-
rons which eventually leads to postsynaptic neuronal
plasticity. Changes in synaptic strength can occur by
altering the activity and/or abundance of postsynaptic
AMPA receptors [19, 31, 42].
Phosphoinositides are phosphorylated derivatives of
phosphoinositol and serve as important second messengers
in the cell. These phosphorylated lipids are produced at
cell membranes during signaling events and contribute to
the recruitment and activation of various signaling compo-
nents as well as the trafficking of intracellular membranes
[4, 6]. Phosphoinositides have emerged as major regulators
of the binding of cytosolic proteins to the bilayer [43],
and there is abundant evidence for the importance of
phosphoinositide pathways in synaptic plasticity [14, 22,
26, 30] and ion channel function [16, 18, 27, 39, 44, 45].
However, despite the large body of evidence for the
relevance of phosphoinositide pathways for synaptic plas-
ticity, very little is known about the influence of
phosphoinositides on glutamate receptor function. The lip-
id phosphatidylinositol 3,4,5-trisphosphate (PIP3) has been
shown to control synaptic function by maintaining AMPA
receptors clustered at the postsynaptic membrane [2], and
for NMDA receptors, it has been suggested that the
phosphoinositide 4,5-bisphosphate (PI(4,5)P2) might be im-
portant for the retention of NMDA receptors at the cell
surface of cortical neurons [23]. Phosphorylation of trans-
membrane AMPA receptor regulatory proteins (TARPs)
regulates synaptic AMPA receptors through interaction
with membrane lipids [40]. Here, we examine the potential
role of the schizophrenia-associated phosphatidylinositol-5-
phosphate 4-kinase, type II, alpha (PIP5K2A) in the reg-
ulation of AMPA receptors. A schizophrenia association
screen identified a point mutation in PIP5K2A (N251S) in
schizophrenia patients [32]. The main product of
PIP5K2A, PI(4,5)P2, is a minor phospholipid component
of cell membranes and enriched in the inner layer of the
plasma membrane where it is a precursor of the second
messengers IP3 and PIP3. Moreover, by regulating func-
tions of numerous ion channels and transporters, it is
considered a second messenger in its own right. We show
a regulatory effect of PI(4,5)P2 on GluA1 receptor func-
tion, prove direct binding of PI(4,5)P2 to a defined amino
acid stretch in the GluA1 C-terminus, and analyze the
interaction between PI(4,5)P2 and GluA1 by an alanine
scan, PIP strip assay, and 3D modeling.
Material and methods
Mutagenesis, cRNAs, peptides, and lipids
The mutations for the alanine scan (K813A, S814A, R815A,
S816A, E817A, S818A, K819A, R820A, M821A, K822A,
G823A) were introduced using the QuikChange II Site-
Directed Mutagenesis Kit (Agilent Technologies, Waldbronn,
Germany) as described in the user manual. The primers used











GC (G823A). Template complementary DNA (cDNA) was
linearized with a suitable restriction enzyme. Complementary
RNA (cRNA) was synthesized from 1 μg of linearized cDNA
using an in vitro transcription kit (mMessage mMachine T7
Kit, Ambion Ltd., Cambridgeshire, UK). cRNA concentrations
were evaluated by spectrophotometry, and transcript quality
was checked by agarose gel electrophoresis. PI(4,5)P2 diC8
(#P-4508, Echelon Biosciences, Inc., Salt Lake City, USA) was
used in the intracellular pipette solution in patch clamp exper-
iments and injection into oocytes, respectively.
Electrophysiological measurements in Xenopus oocytes
Oocytes of stages V–VI were surgically removed from the
ovaries of Xenopus laevis as described elsewhere [33]. Oo-
cytes were injected with GluA1 cRNA (4 ng/oocyte) or to-
gether with PIP5K2A cRNA (4 ng/oocyte) or PIP5K2A-
N251S (4 ng/oocyte) using a nanoliter injector 2000 (WPI,
Berlin, Germany). For the alanine scan, oocytes were injected
with GluA1 cRNA or the respective GluA1 mutant cRNA
(8 ng/oocyte). For coinjections of GluA1 and PIP5K2A
cRNA, 4 ng/oocyte of each cRNA was used. Standard two-
electrode voltage clamp recordings were performed 5–7 days
after cRNA injection, employing a TurboTec 10CX amplifier
(NPI, Tamm, Germany) and a DA/AD-interface DIGIDATA
1322A (Axon Instruments, CA, USA). Data analyses were
done with pClamp/Clampex software (Axon Inc., CA, USA)
and Origin 7.0 software (Additive, Friedrichsdorf, Germany).
Agonist solutions were prepared in ND-96 buffer (96 mM
NaCl, 1.8 mM CaCl2, 2.0 mM KCl, 1.0 mM MgCl2, and
5 mM hydroxyethyl piperazineethanesulfonic acid
(HEPES)–NaOH, pH 7.2 with NaOH, all from Sigma-
Aldrich, Munich, Germany).
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To rule out calcium influences, 1.8 mMCaCl2 was replaced
by 1.8 mMMgCl2, 1.0 mM BaCl2, and 0.3 mM niflumic acid
(pH 7.4 with NaOH) in the recording solution, and in addition,
oocytes were injected with 1,2-bis(2-aminophenoxy)ethane-
N,N,N′,N′-tetraacetic acid (BAPTA; 20 nl of 50 mM BAPTA)
60 min prior to recording. Current and voltage electrodes were
filled with 3 M KCl and had resistances of 0.5–1.5 MΩ.
Oocytes were held at −70 mV, and an agonist (300 μM gluta-
mate, 100 μM cyclothiazide (Tocris, Cologne, Germany)) was
applied by superfusion for 10 s at a flow rate of 10–14 ml/min.
Half maximal effective concentration (EC50) values for gluta-
mate were measured with nine different agonist concentra-
tions. Data from each oocyte were fitted separately with the
GraphPad Prism program to obtain an EC50 value. EC50 values
of five to six oocytes were eventually averaged.
Outside-out current measurements in HEK293 cells
Human embryonic kidney (HEK) 293-T cells were transfected
with GluA1(Q)flip-pIRES2-EGFP using Metafectene Pro
(Biontex, Martiensried, Germany). One day after transfection,
cells were plated onto 30-mm glass bottom dishes (FluoroDish,
World Precision Instruments, Sarasota, FL, USA) at a density of
60,000–80,000 cells per dish. Outside-out recordings were per-
formed 2 days after plating using an EPC-9 amplifier (HEKA
Elektronik, Lambrecht, Germany). Currents were digitized with
a sampling rate of 10 kHz and filtered at 3 kHz. Pipettes were
pulled from borosilicate glass to resistances of 10–15 MΩ. The
extracellular solution contained 140 mM NaCl, 4 mM KCl,
2 mM CaCl2, 1 mM MgCl2, and 10 mM HEPES adjusted to
pH 7.3 with NaOH. The pipette solution contained 130 mM
CsF, 2 mM MgCl2, 1 mM CaCl2, 11 mM EGTA, and 10 mM
HEPES adjusted to pH 7.3 with KOH; PI(4,5)P2 diC8 was
added to the pipette solution to a final concentration of 20 nM.
Brief (10 ms), repetitive (10–100) pulses of glutamate (1 mM)
were applied using a borosilicate theta capillary mounted to a
piezo-driven actuator (PI Physik Instrumente, Karlsruhe, Ger-
many). Capacitances of the excised patches were determined
using the time-domain technique [20]. Nonstationary noise
analysis was performed as described in the literature [11, 37].
For data analysis, the freely available software ANA (M. Pusch)
was used. Statistical analyses were performed using Prism 5.0
(GraphPad Software, San Diego, CA, USA).
Relative abundance of EGFP-tagged GluA1 expression
in HEK293 cells determined by fluorescence microscopy
HEK293 cells were transfected with plasmid DNA (1.5 μg
GluA1 /pEGFP; 1 .36 μg PIP5K2A/pcDNA3 or
PIP5K2A(N251S)/pcDNA3) usingMetafectene Pro (Biontex,
Martinsried, Germany) and after 24 h seeded at a density of
4×104 cells/3.5-cm dish. After another 24 h, the cells were
fixed. For fixation, the 3.5-cm dish plate was washed with 1×
phosphate-buffered saline (PBS) to remove media and treated
with 4 % PFA (Sigma-Aldrich, Taufkirchen, Germany)/PBS
for 15 min. Finally, slides were mounted with Fluoromount
(Sigma-Aldrich, Taufkirchen, Germany), and samples were
examined by fluorescence microscopy (Zeiss Axio
ObserverZ.1, Oberkochen, Germany) with the appropriate
emission band-pass filters for detection of green fluorescent
protein (GFP) and AxioVision 4.8 software. For analysis,
ImageJ software was used.
Determination of intracellular levels of PIP kinases
and membrane expression of GluA1 by Western blot
HEK293 cells were maintained in DMEM (Invitrogen, Darm-
stadt, Germany) supplemented with 10 % fetal bovine serum
(Invitrogen) and 1× non-essential amino acids (Sigma-Aldrich,
Munich, Germany). To determine expression levels of wild-
type and mutant PIP5K2A kinases, cells were plated onto 3.5-
cm dishes at a density of 2.5×105 cells/dish, grown for 48 h,
and then transfected with 3 μg plasmid DNA (PIP5K2A/
pcDNA3 or PIP5K2A(N251S)/pcDNA3) using Metafectene
Pro (Biontex,Martinsried, Germany). Control cells were treated
with Metafectene Pro alone. For lysis of transfected HEK293
cells, the 3.5-cm dish plate was washed with 1× PBS to remove
residual media. Then, 150 μl of 1× cell lysis buffer (# 9803,
Cell Signaling Technology, Danvers, MA, USA)/3.5-cm dish
was added and the plate incubated on ice for 5 min. The cells
were scraped and sonicated briefly, followed by a centrifugation
for 10 min at 14,000×g in a cold microfuge. The supernatant
was removed and stored at −80 °C until needed. Prior to gel
electrophoresis and Western blotting, a protein assay (DC Pro-
tein Assay, Bio-Rad Laboratories, Munich, Germany) was
performed to determine the total protein concentrations. For
Western blotting, 10 μg of total protein was applied per lane.
PIP5K2A monoclonal purified rabbit antibody was used as the
primary antibody (1:1000, #ab109128, Abcam, Cambridge,
UK). For the detection of α-calnexin, primary rabbit α-
calnexin antibody (1:500, sc-11397, Santa Cruz, CA, USA)
was used. The secondary antibody used was horseradish
peroxidase-conjugated sheep anti-rabbit antibody (1:10,000 di-
lution, Amersham Bioscience, Freiburg, Germany).
Cell surface protein isolation
Cell surface protein was isolated according to the manual of
Pierce Cell Surface Protein Isolation Kit from Thermo Scien-
tific, Bonn, Germany (Cat# 89881). Briefly, four 75-cm2 T75
flasks of HEK293-T cells ((1) without DNA, (2) GluA1/
pIRES2/EGFP, (3) GluA1/pIRES2/EGFP+PIP5K2A/
pcDNA3, or (4) GluA1/pIRES2/EGFP+PIP5K2A(N251S)/
pcDNA3) were transfected with or without the corresponding
DNA using the calcium phosphate transfection method. Con-
fluent cells (90–95 %) were incubated with Sulfo-NHS-SS-
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Biotin for 30 min at 4 °C. Cells were scraped and transferred
to a single 50-ml tube after adding a quenching solution to
each flask. Cells were centrifuged (4 °C, 500×g, 5 min) and
transferred into a lysis solution. After sonication, cells were
incubated for 30min on ice, vortexing every 5 min. Cell lysate
was centrifuged (4 °C, 10,000×g, 2 min); clarified supernatant
was transferred to a preparedNeutrAvidin agarose column and
incubated for 60 min at room temperature. After washing of
the column, it was incubated with SDS-PAGE sample buffer
containing DTT for 60 min at room temperature. Elution of
the purified cell surface proteins was performed by centrifu-
gation (4 °C, 1,000×g, 2 min). Samples were analyzed by
Western blot. Antibodies were obtained from Abcam, Cam-
bridge, UK (GluA1, #ab31232, β-Na+/K+-ATPase, #ab2873).
Homogenization of HEK293 cell phospholipid extraction
and PI(4,5)P2 determination by ELISA
Lipid extraction from transfected HEK293 cells was per-
formed as previously described [8]. Briefly, the medium was
aspirated from the culture dish, 1 ml ice-cold 0.5 M TCAwas
added, and the cells were scraped after incubation on ice for
5 min. The cell suspension was centrifuged at 1,500 rpm for
5 min and the pellet washed twice with 1 ml of 5 % TCA+
1 mM EDTA. To remove neutral lipids, 1 ml of methanol/
chloroform (2:1) was added, and the mixture was vortexed
three times for approximately 30 s over a period of 10 min at
room temperature, followed by centrifugation at 1,500 rpm for
5 min. Acidic lipids were extracted from the pellet with 750 μl
of methanol/chloroform/12MHCl (80:40:1) by vortexing four
times over a period of 15 min at room temperature. After
addition of 250 μl of chloroform and 450 μl of 0.1 M HCl,
samples were vortexed vigorously and centrifuged at
1,500 rpm for 5 min. Finally, the lower organic phase was
transferred into a new tube and dried in a vacuum centrifuge.
Determination of cellular PI(4,5)P2 amounts was carried out
using the PI(4,5)P2 Mass ELISA Kit as specified by the user
manual (Echelon Bioscience Inc., Salt Lake City, UT, USA).
Briefly, dried lipid extracts were dissolved in 200–600μl of the
sample buffer (PBS, 0.25 % protein stabilizer), loaded into a
96-well plate, and incubated with a PI(4,5)P2 detector protein.
After incubation, samples were transferred to a PI(4,5)P2-coat-
ed 96-well plate for competitive binding. To determine the
amount of PI(4,5)P2 detector protein binding to the plate, a
peroxidase-conjugated secondary detection reagent was added.
For visualization, a colorimetric substrate was used, and the
absorbance at 450 nm was measured with a microplate reader.
Homology modeling and molecular dynamics simulation
of PIP5K2A and GluA1 structures
Consensus homology models of human PIP5K2A and GluA1
were generated using several individual modeling steps within
YASARA Structure v10.1: The PIP5K2A consensus homolo-
gy model is based on the amino acid sequence Lys21–Thr406,
and the GluA1 homology model represents the amino acid
sequence Leu13–Gly841. Subsequent refinements of high-
resolution models using a CASP-approved protocol were
achieved [17]. The Protein Data Bank (PDB) database was
searched for known structures with a similar sequence using
PSI-BLAST [1] to identify potential modeling templates. The
templates were ranked based on the alignment score and the
structural quality according to WHAT_CHECK [13] obtained
from the PDBFinder2 database [12]. PIP5K2A models were
built for the top-scoring templates (PIP5K2β: 1bo1 and
PIP5K2γ: 2gk9). For both PIP5K2A templates and the GluA1
template (GluA2: 3kg2), the alignment with the target se-
quence was iteratively optimized using the evolutionary infor-
mation contained in related sequences (SwissProt and
TrEMBL), the structural information contained in the template,
and the predicted target secondary structure [15] to obtain a
structure-based alignment correction which is partly based on
SSALN scoring matrices [28]. An indexed version of the PDB
was used to determine the optimal loop anchor points and
collect possible loop conformations if insertions and deletions
and dead-end eliminations were used to find initial rotamer
solutions in the context of a simple repulsive energy function
[5]. The loops were optimized by trying hundreds of different
conformations, reoptimizing the side chains for all of them.
Fine-tuning of side-chain rotamers was performed considering
electrostatic and knowledge-based packing interactions as well
as solvation effects. Using the AMBER03 force field, an
unrestrained high-resolution refinement in explicit solvent
was performed. Final hybrid models were built; bad regions
in the top-scoring models were iteratively replaced with corre-
sponding fragments from other PIP5K2A models. As GluA1
had only one template, no consensus homology model could
be generated. This model is completely based on the solved
GluA2 structure [38] (3kg2.pdb). The resulting consensus
PIP5K2A homology model and the GluA1 homology model
were solved in 0.9 % NaCl solution, and standard molecular
dynamics (MD) simulations were run to relax the model using
YASARA Structure v10.1. The quality of both PIP5K2A and
GluA1 was estimated, and the data are shown in supplemental
Fig. S1 and S2 (Online Resource), respectively.
There is a solved crystal structure of PIP5K2A (2YBX
deposited in the RCSB protein database by Tresaugues L
et al., http://www.rcsb.org/pdb/explore.do?structureId=2YBX),
but it lacks three highly relevant regions for our modeling
(residues 126–130, 294–325, 367–385). Two of these regions
(residues 126–130, 294–325) are directly involved in the
formation of the ligand-binding domains. Therefore, template
structures 1bo1 and 2gk9 from the highly homologous
PIP5K2β/PIP5K2γ represent far better templates to generate a
consensus working model of PIP5K2A. However, comparison
of the modeled structure to the solved parts of the structure of
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PIP5K2A over 284 analyzed residues revealed a relatively small
root-mean-square deviation (RMSD) of 1.87±1.13 Å, further
indicating the relatively high quality of the PIP5K2A model.
Preparation and conduction of PIP5K2A MD simulations
ATP/ADP were docked into the ATP binding site of the
PIP5K2Awild-type (wt) homology model in a similar position
as described for PKA in a procedure described before [29].
Both models were energy-minimized, and PI(4,5)P2 and PI(5)P
were docked to PIP5K2A-ADP and PIP5K2A-ATP, respec-
tively, resulting in the complexes PIP5K2A-ADP–PI(4,5)P2
and PIP5K2A-ATP–PI(5)P. These models were energy-
minimized again. In both model complexes, the residue
Asn251 was mutated to serine to obtain PIP5K2A(N251S)-
ADP–PI(4,5)P2 and PIP5K2A(N251S)-ATP–PI(5)P. All four
models were incorporated in simulation boxes filled with 0.9 %
NaCl–H2O. MD simulations were performed for 2 ns to drive
the models into stable conformations. The following settings
were used: force field AMBER03, temperature at 298 K, pres-
sure at 1 bar, pH 7.0, coulomb electrostatics at a cutoff of 7.86,
0.9%NaCl, solvent density 0.997, 1-fs time steps. The average
structures were determined from the 2,000-ps simulations and
were used to calculate the root-mean-square fluctuations
(RMSFs) for the respective PIP5K2A model (supplemental
Fig. 3, Online Resource). Furthermore, RMSD and energies
were computed. Contacts between ligands and the receptor site
in PIP5K2Awt and N251S were determined using YASARA
Structure v10.1. Superimposed figures of model pairs are
shown in supplemental Fig. 4 (Online Resource).
Preparation and conduction of membrane simulations
of partial GluA1
The GluA1 model generated was elongated at the C-terminal
ends to Gly841 assuming an α-helical structure of the residues
as predicted (supplemental Fig. 2a, Online Resource). The
generated GluA1 homology model comprises 828 residues
(Leu13–Gly841) from four subunits. The total of 3,312 amino
acids represents a relatively large protein complex on which all-
atoms-mobile simulations inmembranes are difficult. As the N-
terminal domain (NTD) is not expected to significantly influ-
ence the inner pore domain, the NTD residues (Leu13–Tyr409)
were removed. The resulting GluA1model comprised only 433
residues (the tetramer has 1,732 amino acids). Four PI(4,5)P2
molecules were generated de novo using ACD/ChemSketch
(version 12.01), manually docked in close proximity to the
residues Ser813–Lys822, and the resultant GluA1–PI(4,5)P2
complex was energy-minimized. The GluA1 model without
PI(4,5)P2 and the GluA1–PI(4,5)P2 complex were both placed
into a simulation box and inserted into a virtual membrane
consisting of equal quantities of phosphatidylethanolamine
(PEA), phosphatidylcholine (PCH), and phosphatidylserine
(PSE; PEA/PCH/PSE—33 %:33 %:33 %). Membrane height
was 43 Å (density ∼0.861 g/l), and the height of the hydropho-
bic membrane core was 28 Å. The GluA1 model without
PI(4,5)P2 and the GluA1–PI(4,5)P2 complex were shrunk to
50 % of their size, and lipids bumping into the shrunk protein
were deleted. Stepwise, the size of the protein/PI(4,5)P2 com-
plexes was expanded to reach their regular size and to fill the
membrane pore. Each expansion step was followed by energy
minimizations. The simulation box was filled with water, and
0.9 % NaCl was added to the system. MD simulations (2 ns)
were performed on GluA1 models in complex with or without
PI(4,5)P2. The following simulation settings were used for the
molecular dynamics simulation: force field AMBER03, tem-
perature at 298 K, pressure at 1 bar, pH 7.0, coulomb electro-
statics at a cutoff of 7.86, 0.9 % NaCl, solvent density 0.997,
pH 7.0, 1-fs time steps, periodic boundaries, all atoms mobile.
The average structures were determined from the simulations
and were used to calculate the RMSFs for the respective model.
Further, RMSD and energies were computed. During a 25-ps
initial equilibration period, the membrane was artificially sta-
bilized so that it could repack and cover the solute, while
solvent water molecules are kept outside the membrane core
for the initial 250 ps of the simulation.
PIP strip assay
PIP strip membranes facilitate the analysis of phosphoinositide
protein interactions by protein–lipid overlay assay. PIP strip
membranes from Life Technologies (Darmstadt, Germany)
were used (# P23750). GluA1 peptide was synthesized by
Caslo (Lyngby, Denmark), and a fluorescein isothiocyanate
(FITC) fluorochrome was conjugated to the N-terminus via
an aminohexanoic acid (Ahx) linker. The GluA1 peptide se-
quence is (FITC)-Ahx-GALIEFCYKSRSESKRMKG. The
first glycine was introduced for more flexibility of the peptide.
The assay was performed as follows: the strip membrane was
blocked with TBS-T+3 % fatty-acid-free bovine serum albu-
min (BSA) (TBS-T=10mMTris–HCl, pH 8.0; 150mMNaCl;
0.1 % (v/v) Tween 20) and gently agitated for 1 h at room
temperature. The peptide was solved in TBS-T+3% fatty-acid-
free BSA and applied to the membrane. The membrane was
incubated with 50μg/ml peptide for 1 h at room temperature by
gentle agitation. The washing of the membrane was performed
three times with TBS-T+3 % fatty-acid-free BSA for 10 min
each time. For detection of fluorescence signal, the Molecular
ImagerTM GelDoc from BioRad (Munich, Germany) was used.
All incubation steps were performed in the dark.
Statistical analysis
Statistical analyses of the data were performed with Origin 7.0.
Student’s t test for unpaired data and ANOVAwas applied, and
p<0.05 was considered statistically significant. Oocyte and
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HEK293 cell experiments were analyzed using Student’s t test,
ANOVA, or Mann–Whitney test, as applicable.
Results
Regulation of GluA1 by PIP5K2A
To test for regulation of GluA1 by PIP5K2A kinase, we heter-
ologously expressed the AMPA receptor subunit GluA1 in
Xenopus oocytes alone or together with PIP5K2A or
PIP5K2A(N251S). The point mutation at position 251 in
PIP5K2A(N251S) was identified by Schwab and colleagues
in schizophrenia patients when performing a schizophrenia
association screen [32]. As illustrated in Fig. 1, the glutamate-
induced currents were significantly larger in Xenopus oocytes
overexpressing GluA1 together with PIP5K2A than in oocytes
expressing GluA1 alone. The stimulating effect of PIP5K2A on
GluA1 was significantly less pronounced when GluA1 was
coexpressed with the PIP5K2A (N251S) mutant (Fig. 1a, b).
Effect of PI(4,5)P2 on electrophysiological features of GluA1
PI(4,5)P2 is the main product of PIP5K2A. To clarify whether
stimulation of GluA1 by PIP5K2A results from an effect of the
lipid product PI(4,5)P2 or another effect of the enzyme, we
injected a water-soluble form of PI(4,5)P2 and determined
GluA1 currents. As illustrated in Fig. 1c, injection of
PI(4,5)P2 before recording caused a significant increase in
GluA1 current amplitudes. This stimulation by PI(4,5)P2 was
not further increased by coexpression of the kinase PIP5K2A
(Fig. 1c), suggesting that PIP5K2A and the major product of
PIP5K2A, PI(4,5)P2, act in the same cascade. The PIP5K2A-
dependent increase in GluA1 current amplitudes could be due
to enhanced membrane abundance of GluA1 subunits and/or a
consequence of changed receptor properties. Analysis of the
EC50 values (glutamate) for GluA1 (17.2±4.5 μM) or for
GluA1 with PIP5K2A (19.6±2.3 μM) or PIP5K2A(N251S)
(10.6±3.6μM) revealed no significant differences when tested
in oocytes (Fig. 1d). In order to test if the effect in oocytes was
due to activation of calcium-activated chloride channels en-
dogenous in oocytes, CaCl2 in the extracellular solution was
replaced byMgCl2 and oocytes were injected with the calcium
chelator BAPTA to buffer cytosolic calcium and to prevent
activation of endogenous calcium-activated channels. Under
these conditions, the PIP5K2A kinases and the water-soluble
PI(4,5)P2 diC8 caused similar albeit slightly smaller but still
significant effects on GluA1 channel functions (Fig. 1e).
In order to analyze fast kinetic properties of the receptor, we
applied the outside-out patch clamp technique to HEK293 cells
transiently transfected with GluA1. In this system, it was possi-
ble to observe effects on GluA1 current amplitudes and GluA1
kinetics upon application of PI(4,5)P2 diC8 via the recording
pipette. Significant changes in current amplitude were found for
GluA1-expressing HEK293 cells exposed to PI(4,5)P2 diC8
compared to cells not exposed to the lipid (Fig. 2a, b). Single-
channel properties were analyzed by non-stationary noise anal-
ysis and showed no significant differences (data not shown). The
macroscopic kinetics was not significantly altered by the PIP2
analog in the pipette (supplemental Fig. S5, Online Resource).
To test for membrane surface GluA1 protein, the relative
abundance of an EGFP-tagged GluA1 expressed alone or to-
gether with PIP5K2A variants was analyzed. GluA1–EGFP
abundance was increased in HEK293 cells coexpressed with
PIP5K2A wt compared to GluA1–EGFP expressed without
additional kinase variants (Fig. 2c, d). Coexpression of GluA1
with PIP5K2A(N251S) resulted in an increase in GluA1 abun-
dance, although not as much as coexpression with PIP5K2A did.
Cell surface protein isolation also revealed an increase of mem-
braneGluA1 after coexpressionwith PIP5K2A inHEK293 cells,
although a reduction of GluA1 expression upon coexpression
with PIP5K2A(N251S) compared to GluA1 alone was observed
(Fig. 2e). Therefore, enhanced GluA1 plasmamembrane expres-
sion as a result of activation of the PIP5K2A–PI(4,5)P2 cascade
may be the reason for the increase in GluA1 function.
PI(4,5)P2 assay for PIP5K2A and PIP5K2A(N251S)
The impact of the schizophrenia-associatedmutation N251S on
the function of PIP5K2A thus far has not been investigated.
The main catalytic function of PIP5K2A is the phosphorylation
of PI(5)P to produce PI(4,5)P2. To test whether the mutation
N251S affects PIP5K2A function, we performed a quantitative
PI(4,5)P2 assay. After the treatment of HEK293 cells with
transfection reagent plus PIP5K2A or PIP5K2A(N251S)
cDNA or with transfection reagent alone, we first verified the
overexpression of both PIP5K2A variants and the comparabil-
ity of their expression levels via Western blot (Fig. 3a). Mock-
transfected HEK293 cells as well as HEK293 cells transfected
with either PIP5K2A or PIP5K2A(N251S) were lysed and the
lipids isolated. Then, a specific PI(4,5)P2 ELISA was per-
formed to compare PI(4,5)P2 production by PIP5K2A or
PIP5K2A(N251S). As shown in Fig. 3b, HEK293 cells over-
expressing PIP5K2A show a significant increase in PI(4,5)P2
amounts compared to mock-transfected cells. In contrast, the
PI(4,5)P2 amounts of HEK293 cells expressing the mutant
kinase PIP5K2A(N251S) were twofold lower compared to
cells expressing wild-type PIP5K2A and on the same level as
mock-transfected cells, supporting the notion that the mutation
N251S results in reduced kinase activity.
Molecular simulations of PIP5K2Awt and PIP5K2A(N251S)
We constructed a PIP5K2A homology model to visualize the
catalytic domain of PIP5K2A and the location of the N251S
mutation in PIP5K2A (Fig. 3c–f). The model was based on
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phosphatidylinositol phosphate kinase, type II, beta (PIP5K2β)
(1bo1A and 2gk9). PIP5K2A residues 29 to 406 could be
modeled on ∼70 % sequence identity to PIP5K2β and
PIP5K2γ. ATP/ADP, PI(5)P, and PI(4,5)P2 were docked into
the ATP binding site of the PIP5K2Awt homology model in a
similar position as proposed for PIP5K2β [29], resulting in the
complexes PIP5K2A-ATP–PI(5)P (Fig. 3c) and PIP5K2A-
ADP–PI(4,5)P2 (Fig. 3d). In both model complexes, the residue
Asn251 was mutated to serine to obtain PIP5K2A(N251S)-
ADP–PI(4,5)P2 and PIP5K2A(N251S)-ATP–PI(5)P. On all four
models, 2-ns MD simulations were performed. Overlays of the
final structures are shown in Fig. 3c, d. Particular differences can
be observed in the PIP5K2A(N251S)-ATP–PI(5)P complex as a
result of the mutation (see also supplemental Fig. S3–S4, Online
Resource). In order to gain insights into the mechanism of
reduced catalytic activity of PIP5K2A(N251S), we analyzed
the number of atomic contacts. It can be assumed that the larger
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Fig. 1 Effects of PIP5K2A or PI(4,5)P2 but not of PIP5K2A(N251S) on
properties of GluA1 currents in oocytes. a Representative current traces
measured in Xenopus oocytes in response to superfusion with 300 μM
glutamate and 100 μM cyclothiazide. All currents were measured at
−70 mV. Steady-state currents (indicated by arrows) were used for
analysis. b GluA1 current amplitudes in oocytes expressing GluA1,
GluA1+PIP5K2A, or GluA1+PIP5K2A(N251S) normalized to the
GluA1 currents. Numbers of oocytes vary between 23 and 35, and
significant changes are indicated by ***p<0.001, **p<0.01, or
*p<0.05. c GluA1 current amplitudes in oocytes expressing GluA1 or
GluA1+PIP5K2A are shown. For bars 2 and 4, PI(4,5)P2 was acutely
injected 5 min prior to measurements. Numbers of oocytes varied
between 12 and 17, and significant changes are indicated by **p<0.01.
Striped bars indicate results after injections of oocytes with water-soluble
PI(4,5)P2. d Concentration–response curves for glutamate of GluA1,
GluA1+PIP5K2A, and GluA1+PIP5K2A(N251S) expressed in oocytes.
Mean values±SEMwere calculated from independent measurements (n=
5–6). e Oocytes were injected with BAPTA prior to the experiments.
GluA1 current amplitudes were determined in oocytes expressing GluA1
orGluA1+PIP5K2A, without or after acute injectionwith a water-soluble
PI(4,5)P2 analog. Numbers of oocytes varied between 17 and 26, and
significant changes are indicated by **p<0.01 or *p<0.05. Striped bars
indicate results from oocytes injected with water-soluble PI(4,5)P2 prior
to recording
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the stronger the interaction energy and the more stable the
ligand–receptor complex. Thus, enzyme–ligand complexes sim-
ilarly should have many contact points (and thus interaction
energies) to avoid energetic barriers during a catalytic cycle.
Our simulations imply that this holds true for the PIP5K2Awt
ADP–PI(4,5)P2 and PIP5K2A wt ATP–PI(5)P but not for the
PIP5K2A(N251S)-ADP–PI(4,5)P2 and PIP5K2A(N251S)-
ATP–PI(5)P complexes. The PIP5K2A(N251S)-ATP–PI(5)P
complex has more contact points than the PIP5K2A(N251S)-
ADP–PI(4,5)P2 complex. The former complex can be assumed
to be more stable, creating an energy barrier during the
catalytic circle and reducing the catalytic activity of
PIP5K2A(N251S).
Definition of the PI(4,5)P2-sensitive region in GluA1
Our data point to an effect of PI(4,5)P2 on GluA1. We
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a
Fig. 2 Effect of PI(4,5)P2 on properties of GluA1 currents and of
PIP5K2A on GluA1 plasma membrane expression. aOverlay of GluA1
currents in the absence (black trace) and presence (red trace) of PI(4,5)P2
diC8; traces represent averages of 10–20 repeated applications. bMean
peak amplitudes (±SEM) of peak currents evoked by 10-ms application of
1 mM glutamate are shown. Under control conditions, the mean peak
current amplitude was 22±4 pA. When PI(4,5)P2 diC8 was present in the
pipette solution, the mean peak current was significantly larger (70±
11 pA, **p=0.0009, n=10, Mann–Whitney test). To compensate for
patches of different sizes, current densities were calculated (control: 32
±6 pA/pF, PI(4,5)P2 diC8: 66±13 pA/pF; *p=0.0019, n=10, Mann–
Whitney test). c Representative pictures taken from HEK293 cells
transfected with GluA1-EGFP alone or GluA1-EGFP together with the
kinases PIP5K2A or PIP5K2A(N251S). Dashed lines indicate the posi-
tion of intensity analysis. dAnalysis of GFP fluorescence intensity at the
plasma membrane. Line plots were analyzed and the mean data±SEM is
shown. The estimated position of the membrane (arrow) and the side of
the cytosol are indicated. Number of cells analyzed: GluA1: n=53,
GluA1+PIP5K2Awt: n=55, GluA1+PIP5K2A(N251S): n=66. e West-
ern blot of membrane GluA1 expression level in HEK293 cells after
coexpression with either PIP5K2A or PIP5K2A(N251S) or GluA1
expressed alone. As control, only transfection reagent was transfected
(lane 1). β-Na+/K+-ATPase was used as control protein
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GluA1, the binding region should be located in close
proximity to the inner leaflet of the plasma membrane.
The C-terminal amino acids K813–G823 span the region
closest to the inner leaflet of the membrane. Therefore, we
performed an alanine scanning mutagenesis of this stretch
of the GluA1 sequence. As shown in Fig. 4a, all GluA1
alanine mutants were functional ion channels, and some
even revealed a considerable increase in current amplitudes
compared to GluA1 wild type when expressed in Xenopus
oocytes.
To test for their possible involvement in PI(4,5)P2
binding, we coexpressed the GluA1 mutants (K813A–
G823A) with PIP5K2A in oocytes and determined max-
imal current amplitudes. Alanine mutations at positions
S814, S816, and E817 showed increased current ampli-
tudes upon coexpression with PIP5K2A. For the other
eight mutations (K813A, R815A, S818A, K819A,
R820A, M821, K822A, and G823A), the sensitivity of
currents to coexpression with PIP5K2A was lost, indi-
cating that those amino acids might be involved in
PI(4,5)P2 binding (Fig. 4b). The model shown in
Fig. 4c depicts the likely orientation of side chains of
amino acids possibly involved in PI(4,5)P2 binding
(magenta) compared to those unlikely to be involved
(blue). By using PIP strip membranes, we analyzed the
binding of a GluA1 peptide, including the above identified
amino acids possibly involved in PI(4,5)P2 binding, to phos-
pholipids. The peptide was labeled at the N-terminal with
FITC for easy fluorescence detection. The assay proved direct
binding of the GluA1 peptide to PI(4,5)P2 as well as to PIP,
PI(3,5)P2, PI(3,4)P2, PI(3,4,5)P3, and phosphatidic acid
(Fig. 4d).
Therefore, these results of the alanine scan and the PIP strip



































































































































Fig. 3 Reduced PI(4,5)P2 production by PIP5K2A(N251S) could be a
result of structural changes at the catalytic site of the mutant. aRepresen-
tative Western blot of either mock-transfected HEK293 cells or HEK293
cells transfected with PIP5K2A or PIP5K2A(N251S) cDNA.α-Calnexin
was used as a marker for proper loading. Bar graph showing the total
protein abundance of PIP5K2A protein of mock-transfected HEK293
cells and HEK293 cells transfected with PIP5K2A or PIP5K2A(N251S)
cDNA. The band intensity was quantified by densitometry. Number of
experiments used for analysis, n=7. b ELISA assay for detection of
PI(4,5)P2 in HEK293 cells expressing either PIP5K2A or
PIP5K2A(N251S). Standard curve shows absorbance values obtained
versus amount of standard PI(4,5)P2 concentrations. Below, graph shows
concentrations of PI(4,5)P2 in mock-transfected cells in comparison to
cells expressing either PIP5K2A or PIP5K2A(N251S). Significant
change is indicated by ***p<0.001 or *p<0.05 (n=6–7). c–fMolecular
dynamics simulations of PIP5K2A wt and PIP5K2A(N251S). c, d A
PIP5K2A wt homology model is depicted. ATP/ADP, PI(4,5)P2, and
PI(5)P were docked into the ATP binding site of the PIP5K2A wt
(turquoise) and mutant homology model (red) in a similar position as
proposed for the related kinase PIP5K2B, resulting in the complexes
PIP5K2A-ADP-PI(4,5)P2, PIP5K2A-ATP-PI(5)P, PIP5K2A(N251S)-
ADP-PI(4,5)P2, and PIP5K2A(N251S)-ATP-PI(5)P. MD simulations
covering 2,000 ps were performed on all four models. Overlays of the
final structures are shown in c and d. e, f The affinity of a ligand to its
receptor increases with increasing numbers of atom contacts as a result of
increased van der Waals interactions. The number of contacts of the
respective ligands ATP/ADP and PI(5)P/PI(4,5)P2 with their receptors
in PIP5K2Awt (red) and PIP5K2A(N251S) (turquoise) were determined.
The combined interactions of both ligands with the respective kinase
determine the stability of the enzyme-ligand complexes. The combined
number of contacts of both ligands with the kinase receptors is shown in f.
The marked differences in contacts between ATP/PI(5)P and ADP/
PI(4,5)P2 indicate an increased interaction and thus an increased affinity
for ATP/PI(5)P
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terminus of GluA1, which is in close proximity of the inner
plasma membrane.
Structure of the GluA1/PI(4,5)P2 complex based
on homology modeling
Our GluA1 model represents the residues 433–841 including
the C-terminal end, assuming an α-helical structure of these
residues, as predicted by the PSIPRED server (Fig. 4c). Four
PI(4,5)P2 molecules (one PI(4,5)P2 for each subunit) were
manually docked in close proximity to the residues Ser813–
Lys822 (Fig. 5a). The GluA1 model without PI(4,5)P2 and the
modeled GluA1–PI(4,5)P2 complex were inserted into a PEA,
PCH, or PSE membrane (33 %:33 %:33 %). MD simulations
(2,000 ps) were performed on both models, and mean RMSD
calculations suggested that the models had reached a stable
conformation during the simulation (Fig. 5b). Calculation of
the RMSFs for each model indicated that extracellular regions
are flexible whereas membrane-spanning regions and the
putative PI(4,5)P2-interacting regions (residues 813–823) are
rather rigid, consistent with the idea that conformational space
of residues in these regions is restricted by the surrounding
membrane. As residues 813–823 are positioned outside the
membrane core, stabilization may result from interaction with
the PI(4,5)P2 headgroups. Indeed, stabilizing electrostatic in-
teractions of specifically Lys815, Lys819, Arg820, and
Lys822 side chains with the negatively charged PI(4,5)P2 head
group occur during the simulation and can be observed in the
averaged structural models (Fig. 5c).
Discussion
PI(4,5)P2 is the main product of PIP5K2A, a kinase which is
associated with schizophrenia [32]. Interestingly, GluA1 has
also been implicated in the pathophysiology of schizophrenia
[9, 21, 24, 25]. Decreased expression levels of GluA1 have
been found in the brain of some schizophrenic patients. GluA1
has also been connected with genetic susceptibility for schizo-
phrenia [21]. However, as mentioned above, schizophrenia is
a complex multifaceted disorder, and it has to be considered
that under some conditions, an alteration of AMPA receptor
conductance within the nervous system may induce other
physiological events that induce behaviors that meet the
criteria for classification as schizophrenia.
Here, we find that the schizophrenia-associated kinase mu-
tant PIP5K2A(N251S) less effectively produces PI(4,5)P2. Ho-
mology modeling and molecular dynamics simulation suggest
that the mutation has a relatively global effect on PIP5K2A
structure and dynamics. As the distances between residue N251
and the ligands are relatively large (Cα-PIP ∼31 Å, Cα-ATP
∼27 Å), the effects on protein structure and function must be of
allosteric nature. Possibly, the relatively global effects on the
protein structure by themutation result from destabilization of a
loop (residues 215–251) involved in the formation of both











































































































































Fig. 4 Alanine scan and PIP strip assay reveal the binding of PI(4,5)P2 to
the C-terminal domain of GluA1. a Glutamate+cyclothiazide-evoked
current amplitudes in oocytes expressing GluA1 or GluA1 point mutants
(K813A through G823A) normalized to the GluA1 currents. Statistically
significant current changes of the mutants compared to GluA1 wt are
indicated by ***p<0.005 or **p<0.01. bGluA1 or GluA1 point mutant
current amplitudes in oocytes with (right bars) or without (left bars)
coexpression of PIP5K2A. Blue bars indicate that the PI(4,5)P2 effect is
present; magenta bars indicate an impaired PI(4,5)P2 effect. Numbers of
oocytes measured, n=10–35. Statistically significant current changes of
GluA1 by PIP5K2A are indicated by ***p<0.005 or *p<0.05. c Confi-
dence level of a predicted α-helical secondary structure of a GluA1
peptide and 3Dmodel of the region of GluA1 chosen for the alanine scan
are shown. The same color code used as for the bar diagram in b, where
blue indicates amino acids probably not involved in PI(4,5)P2 binding
while magenta indicates amino acids that may play a role in PI(4,5)P2
binding. dN-terminal FITC-labeled GluA1 peptide shows binding to PIP,
PIP2, and PIP3. PIP strip membranes were used for the detection of
peptide binding to various lipids. 1=lysophosphatidic acid, 2=
lysophosphatidylcholine, 3=phosphadidylinositol, 4=PtdIns(3)P, 5=
PtdIns(4)P, 6=PtdIns(5)P, 7=phosphatidylthanolamine, 8=phosphatidyl-
choline, 9=spingosine 1-phosphate, 10=PtdIns(3,4)P2, 11=
PtdIns(3,5)P2, 12=PtdIns(4,5)P2, 13=PtdIns(3,4,5)P3, 14=phosphatidic
acid, 15=phosphatidylserine, 16=blank
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may determine access of ligands and stability of the ligand–
protein complexes as suggested by the MD simulations. As a
result of the mutation, an energetic barrier in the catalytic cycle
may prevent high-throughput catalyses as suggested by our
MD simulations (Fig. 3).
It is known that PI(4,5)P2 is a quantitatively minor phos-
pholipid component of cell membranes and enriched at the
plasma membrane where it is an important substrate for sev-
eral signaling proteins, including several ion channels [7].
Here, we show that the stimulating effect of PI(4,5)P2 on
GluA1 currents is caused by direct binding to the C-
terminus of GluA1 rather than a consequence of activation
of second messengers by PI(4,5)P2. Our 3D molecular model
suggests that PI(4,5)P2 stimulates GluA1 by interaction with
the plasma membrane-adjacent region of the GluA1 C-
terminus. A similar effect has recently been shown for the
transmembrane AMPA receptor regulatory protein (TARP)
molecules [40]. The TARP stargazin appears to interact with
negatively charged lipid bilayers in a phosphorylation-
dependent manner. In a non-phosphorylated state, TARPs
interact with negatively charged lipid bilayers, which inhibit
TARP (stargazin) binding to PSD-95. When TARPs are





























Fig. 5 Molecular dynamics simulations of GluA1 alone and in complex
with PI(4,5)P2. a A GluA1 wt homology model was built for residues
410–841. In the case of GluA1 in the presence of 4 PI(4,5)P2, one
phospholipid per subunit was manually docked in close proximity to
the residues (Lys833, Lys837, Arg838, and Lys840) identified in the
alanine scan as PI(4,5)P2-relevant residues (Fig. 4e). GluA1-PI(4,5)P2
was inserted into a PEA/PCH/PSE (each 33 %) membrane. A 2,000-ps
MD simulation was performed (details are given in “Material and
methods”). The final averaged structure is shown in a. A close-up of the
partial inner pore with backbone structures (yellow) within the surface
(blue) and cut at the center of the pore is shown in the upper right figure.
The position of the membrane core is indicated. The inner pore following
the selectivity filter (sf) forms a bowl-like structure (green dotted line).
The lower figure shows PI(4,5)P2 (in CPK colors), and the effective
residues and non-effective residues identified in the alanine scan are
colored magenta and blue, respectively. b The mean RMSD±SEM of
the complete models compared to the initial structures are shown. c The
RMSFs of residues compared to the averaged structure are shown
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phosphorylated, binding to PSD-95 is possible, resulting in
enhancement of synaptic AMPA receptor activity [40]. Our
observations allow a similar interpretation: the binding of
PI(4,5)P2 to the C-terminus of GluA1 could impair binding
of regulatory molecules, thus modifying receptor activity by
increasing GluA1 protein at the plasma membrane resulting in
increased ion channel function by altered clustering. This
interpretation is supported by our suggestive experimental
data as well as the 3D modeling. Interestingly, GluA1 amino
acids shown here to be crucial for PIP2/PIP3 binding have also
been reported to be the sites for phosphorylation,
palmitoylation, and Band 4.1 interaction, implying complex
cross talk of regulating signals [3, 10]. The group of Esteban
identified PIP3 as a lipid-controlling synaptic function by
maintaining AMPA receptor clustering at the postsynaptic
membrane [2]. The mechanism of PIP3 action was not exam-
ined in that publication. Theoretically, by increasing the pool
of diphosphoinositol, the pool of triphosphoinositol could be
increased secondarily to enhance GluA1 stimulation. It seems
rather likely that both PIP2 and PIP3 are involved in clustering
processes, especially since we show that the identified GluA1
sequence seems to be a promiscuous binding site of PIP, PIP2,
and PIP3. In a previous study, we showed the regulation of
GluA1 by PIKfyve, which produces PI(3,5)P2 ([34]), the most
abundant phospholipid in recycling vesicles. It can be as-
sumed that the locally most abundant phospholipid preferen-
tially binds to the identified GluA1 sequence. Therefore, it
may depend on the localization of the receptor which phos-
pholipid binds to it. In recycling vesicles, PI(3,5)P2 is the most
abundant phospholipid, and at plasma membranes, PI(4,5)2
and PI(3,4,5)P3 are most abundantly expressed. Additionally,
the local concentration of the respective phospholipid species
is possibly determined by the locally present kinases. It is
reasonable to assume that a functionally impaired kinase like
PI5K2A(N251S) may disturb local PIP compositions leading
to altered cellular function and possibly diseases including
schizophrenia.
In conclusion, the present observations disclose a novel
mechanism regulating GluA1 function that may contribute to
the pathogenesis of schizophrenia. Furthermore, we show for
the first time that PI(4,5)P2 directly interacts with the C-
terminus of GluA1. Finally, we propose the structure of this
carboxyterminal region of GluA1 based on homology
modeling.
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